Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1111/j.1398-9995.2007.01620.x | Allergic Rhinitis and its Impact on Asthma (ARIA) 2008* |
| https://doi.org/10.1111/jdv.14891 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I |
| https://doi.org/10.1111/jdv.14888 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II |
| https://doi.org/10.1186/1471-2466-6-13 | Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study |
| https://doi.org/10.1111/jdv.18345 | European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy |
| https://doi.org/10.1111/all.13208 | Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis |
| https://doi.org/10.1111/all.13749 | EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma |
| https://doi.org/10.1111/all.15902 | EAACI guidelines on the diagnosis of IgE ‐mediated food allergy |
| https://doi.org/10.1111/all.14425 | EAACI Biologicals Guidelines—Recommendations for severe asthma |
| https://doi.org/10.1111/jdv.18429 | European guideline ( EuroGuiDerm ) on atopic eczema – part II : non‐systemic treatments and treatment recommendations for special AE patient populations |
| https://doi.org/10.1186/gm259 | Systems medicine and integrated care to combat chronic noncommunicable diseases |
| https://doi.org/10.1016/j.jaci.2016.12.940 | Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes |
| https://doi.org/10.1111/j.1398-9995.2007.01425.x | The prevalence, cost and basis of food allergy across Europe |
| https://doi.org/10.1186/2045-7022-2-21 | Research needs in allergy: an EAACI position paper, in collaboration with EFA |
| https://doi.org/10.1111/all.12686 | MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation |
| https://doi.org/10.1111/j.1398-9995.2010.02534.x | MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine |
| https://doi.org/10.1016/j.buildenv.2015.08.011 | What does the scientific literature tell us about the ventilation–health relationship in public and residential buildings? |
| https://doi.org/10.1016/j.jaci.2016.03.025 | MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis |
| https://doi.org/10.1016/j.jaci.2018.08.049 | Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology |
| https://doi.org/10.1186/s13601-016-0137-4 | ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle |
| https://doi.org/10.1111/jdv.15634 | Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults |
| https://doi.org/10.1111/all.16345 | EAACI guidelines on the management of IgE‐mediated food allergy |
| https://doi.org/10.1183/16000617.00008114 | National and regional asthma programmes in Europe |
| https://doi.org/10.1097/aci.0b013e3282f3f42f | The voice of the patients: allergic rhinitis is not a trivial disease |
| https://doi.org/10.1186/s13601-018-0227-6 | MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence |
| https://doi.org/10.1111/all.14809 | Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines |
| https://doi.org/10.1186/s13601-019-0252-0 | Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma |
| https://doi.org/10.1186/s13601-019-0279-2 | Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases |
| https://doi.org/10.1111/all.12637 | Are allergic multimorbidities and IgE polysensitization associated with the persistence or re‐occurrence of foetal type 2 signalling? The M e DALL hypothesis |
| https://doi.org/10.1183/09031936.00053108 | The Brussels Declaration: the need for change in asthma management |
| https://doi.org/10.1159/000509057 | Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review |
| https://doi.org/10.1111/j.1398-9995.2010.02439.x | Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper |
| https://doi.org/10.1183/09031936.00150910 | Inhaler devices for asthma: a call for action in a neglected field: Table 1– |
| https://doi.org/10.1111/all.12880 | Paving the way of systems biology and precision medicine in allergic diseases: the Me DALL success story |
| https://doi.org/10.2340/00015555-3102 | Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries |
| https://doi.org/10.1111/jdv.20639 | European Guideline ( EuroGuiDerm ) on atopic eczema: Living update |
| https://doi.org/10.1111/all.14408 | Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA |
| https://doi.org/10.1016/j.jaci.2012.01.047 | Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: A Mechanisms of the Development of Allergy (MeDALL) Seminar |
| https://doi.org/10.4193/rhin17.253 | mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology |
| https://doi.org/10.1186/s13601-017-0186-3 | European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) |
| https://doi.org/10.1111/all.13701 | ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy” |
| https://doi.org/10.1111/all.14422 | ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice |
| https://doi.org/10.1111/all.15275 | Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data |
| https://doi.org/10.1183/13993003.00606-2022 | Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA) |
| https://doi.org/10.2174/1381612820666140314115505 | Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies |
| https://doi.org/10.1186/s13601-016-0116-9 | Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) |
| https://doi.org/10.1007/s12603-016-0803-1 | Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA |
| https://doi.org/10.1002/clt2.12014 | ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy |
| https://doi.org/10.1111/all.12819 | European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015) |
| https://doi.org/10.4193/rhin17.028 | EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis |
| https://doi.org/10.1186/s13601-017-0173-8 | CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report |
| https://doi.org/10.1016/j.jaip.2024.06.040 | Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024) |
| https://doi.org/10.1111/pai.14129 | Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO |
| https://doi.org/10.1183/13993003.00691-2024 | Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma |
| https://doi.org/10.1016/j.waojou.2025.101123 | Food allergy severity across the world: A World Allergy Organization international survey |
| https://doi.org/10.1111/j.1398-9995.2009.02059.x | GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’ |
| https://doi.org/10.1111/j.1398-9995.2004.00720.x | Information provision for allergic consumers – where are we going with food allergen labelling? |
| https://doi.org/10.1186/s40900-015-0004-9 | From tokenism to meaningful engagement: best practices in patient involvement in an EU project |
| https://doi.org/10.1111/j.1398-9995.2008.01653.x | Primary care: the cornerstone of diagnosis of allergic rhinitis |
| https://doi.org/10.1186/s13601-017-0160-0 | Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews |
| https://doi.org/10.1111/j.1398-9995.2012.02822.x | Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union |
| https://doi.org/10.1111/all.13218 | Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project) |
| https://doi.org/10.1111/all.13856 | Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases |
| https://doi.org/10.1136/bmj.k4680 | Respiratory disease mortality in the United Kingdom compared with EU15+ countries in 1985-2015: observational study |
| https://doi.org/10.1111/j.1398-9995.2008.01944.x | Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project |
| https://doi.org/10.1186/s13601-019-0242-2 | Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases |
| https://doi.org/10.1016/j.jaip.2020.01.059 | Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank |
| https://doi.org/10.1111/all.12258 | Improving allergy management in the primary care network - a holistic approach |
| https://doi.org/10.1183/23120541.00444-2022 | Definitions of non-response and response to biological therapy for severe asthma: a systematic review |
| https://doi.org/10.1186/s13601-020-00321-2 | Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing |
| https://doi.org/10.1183/16000617.0132-2021 | ERS/EAACI statement on adherence to international adult asthma guidelines |
| https://doi.org/10.1111/jdv.19269 | First update of the living European guideline ( EuroGuiDerm ) on atopic eczema |
| https://doi.org/10.1111/all.14838 | Management of anaphylaxis due to COVID‐19 vaccines in the elderly |
| https://doi.org/10.1183/13993003.02107-2022 | Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials |
| https://doi.org/10.3390/jcm9082397 | The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians |
| https://doi.org/10.1183/13993003.01231-2022 | Identifying and appraising outcome measures for severe asthma: a systematic review |
| https://doi.org/10.1186/s13601-016-0094-y | Allergen immunotherapy for allergic asthma: protocol for a systematic review |
| https://doi.org/10.1007/s40629-019-0098-y | Atopic eczema score of emotional consequences—a questionnaire to assess emotional consequences of atopic eczema |
| https://doi.org/10.1002/clt2.70002 | GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management |
| https://doi.org/10.1111/all.15857 | Addressing adverse synergies between chemical and biological pollutants at schools—The ‘ SynAir‐G ’ hypothesis |
| https://doi.org/10.23736/s2784-8671.24.07664-3 | Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA) |
| https://doi.org/10.1002/clt2.12299 | A concept for integrated care pathways for atopic dermatitis—A GA 2 LEN ADCARE initiative |
| https://doi.org/10.1002/clt2.70013 | Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA 2 LEN and EFA consensus statement |
| https://doi.org/10.1111/all.70182 | EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention |
| https://doi.org/10.2147/copd.s527932 | Addressing the Most Critical Challenges in COPD: An Expert Review of Emotional, Economic, and Evidence-Based Perspectives |
| https://doi.org/10.1111/j.1398-9995.2005.00868.x | A framework for measuring costs to society of IgE‐mediated food allergy |
| https://doi.org/10.1111/j.1398-9995.2006.01106.x | Working towards healthy air in dwellings in Europe |
| https://doi.org/10.1111/j.1398-9995.2006.01304.x | The limitations of severe asthma: the results of a European survey |
| https://doi.org/10.1183/23120541.00076-2018 | Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma |
| https://doi.org/10.1111/all.12115 | Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing |
| https://doi.org/10.4193/rhin19.012 | Patient Advisory Board for Chronic Rhinosinusitis – A EUFOREA initiative |
| https://doi.org/10.1159/000431359 | Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway |
| https://doi.org/10.1002/clt2.12128 | Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model |
| https://doi.org/10.1183/13993003.02168-2021 | 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD |
| https://doi.org/10.1183/13993003.02294-2016 | Asthma research in Europe: a transformative agenda for innovation and competitiveness |
| https://doi.org/10.1038/s41533-025-00465-3 | A guide for a patient-centric approach to asthma management: results of a European Delphi consensus programme |
| https://doi.org/10.1080/15412555.2020.1788526 | Daily Impact of COPD in Younger and Older Adults: Global Online Survey Results from over 1,300 Patients |
| https://doi.org/10.1111/cea.12779 | Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument |
| https://doi.org/10.21037/jtd-21-792 | Digital Health Europe (DHE) Twinning on severe asthma—kick-off meeting report |
| https://doi.org/10.1111/all.15789 | Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspective |